Mobile Health Solutions to rectify digital inequality in communities affected by drug addiction (R43/R44 Clinical Trial Optional) | Apply Online

Opportunity Summary:

The Mobile Health Solutions to rectify digital inequality in communities affected by drug addiction (R43/R44 Clinical Trial Optional) funding opportunity, listed as RFA-DA-22-001, is a National Institute on Drug Abuse (NIDA) Small Business Innovation Research (SBIR) grant program under the National Institutes of Health (NIH). Its central goal is to spur U.S. small businesses to create and test mobile health (mHealth) tools that can reduce digital inequities experienced by underserved and vulnerable people living with Substance Use Disorders (SUD). In practice, this means NIDA is looking for technology-driven solutions that do more than simply deliver an app; they should be designed to work in real-world conditions where access to reliable internet, up-to-date smartphones, stable housing, consistent clinical care, or digital literacy cannot be assumed.

The FOA encourages development of mobile health technologies broadly, including smartphone-based interventions, wearables (such as sensors, smartwatches, or other body-worn devices), and other digitally enabled health tools that can support prevention, treatment, and recovery for drug addiction while explicitly accounting for gaps in access and usability. “Digital inequality” in this context can include barriers like limited broadband availability, insufficient data plans, lack of compatible devices, low digital literacy, disability-related accessibility needs, language barriers, or mistrust and privacy concerns that reduce willingness to engage with digital services. Competitive projects would typically show a clear plan for how the product will remain usable and effective for people who are most likely to be left out of standard digital health approaches, for example by enabling offline functionality, low-bandwidth operation, simplified onboarding, multilingual content, accessible design, or integration with low-cost hardware.

Because the mechanism is SBIR R43/R44, the opportunity is aimed specifically at small business concerns rather than universities or large health systems acting as lead applicants. R43 generally refers to the Phase I SBIR effort focused on feasibility and early proof-of-concept, while R44 generally refers to Phase II work that expands development and produces stronger evidence for performance, effectiveness, and readiness for broader deployment or commercialization. The “Clinical Trial Optional” label indicates that applicants may propose studies that meet the NIH definition of a clinical trial, but they are not required to do so; both trial and non-trial development pathways can be appropriate depending on the maturity of the technology and the evidence needed. In either case, the expectation is that projects move toward real-world impact, meaning solid user-centered design with the target communities, thoughtful validation, and a credible route to adoption in settings that serve people with SUD (such as community clinics, harm reduction programs, recovery organizations, rural health providers, criminal justice reentry services, or social service agencies).

Eligibility is limited to U.S. small businesses. Non-U.S. (foreign) institutions are not eligible to apply, and non-U.S. components of U.S. organizations are not eligible to apply. However, foreign components, as defined by the NIH Grants Policy Statement, may be allowed in some cases, which typically means certain discrete project elements could occur outside the U.S. if they are well justified and permitted under NIH policy, but the applicant organization itself must be an eligible U.S. small business and the core project leadership and control must remain compliant with SBIR rules.

Administratively, the FOA falls under CFDA 93.279, is categorized as a discretionary grant, and is associated with education and health activities. The notice was created on April 27, 2021, with an original closing date of August 13, 2021. While the provided source information does not list an award ceiling or the number of expected awards, applicants would normally look to the full FOA and NIH SBIR budget guidelines to understand allowable costs, phase-specific budget caps or waivers, and other standard NIH requirements.

Overall, this opportunity is best understood as a targeted push to develop practical, scalable, and equitable mobile and wearable health solutions for addiction-related care, with a strong emphasis on closing the gap between what digital health tools can do in ideal conditions and what they can realistically do for communities that face the steepest barriers to access, continuity of care, and sustained engagement.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education, Health

Next opportunity: NAWCA 2022-2 US Standard Grants

Previous opportunity: Identification of Positive Valence System Related Targets for Novel Suicide Prevention Approaches (R21 Clinical Trial Optional)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA DA 22 001

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (RFA DA 22 001) also looked into and applied for these:

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA DA 22 001", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.